Uncategorized – Page 314

Insmed’s Stocks Skyrocket Following Triumphant Phase III Results for Brensocatib in Bronchiectasis Treatment

1 year ago talkbio0Tagged Approved, brensocatib, Bronchiectasis, Insmed, Lung diseases, Market, New Drug Application, Phase 3 Clinical Trials, surge, United States Food and Drug Administration

Insmed, brensocatib, bronchiectasis, Phase III trial, lung disease, stock surge, New Drug Application, FDA approval, market value

BioNTech Expands ADC Alliance with MediLink, Investing $1.8 Billion

1 year ago talkbio0Tagged ADC, alliance, BioNTech, gene therapy, MediLink, Molecular Biology, oligonucleotide therapy, therapeutic autologous dendritic cells

BioNTech, MediLink, ADC alliance, $1.8 billion, oligonucleotide therapy, gene therapy, molecular biology

Gilead and Cartography Collaborate to Identify Novel Antigen Targets for Cancer Therapy

1 year ago talkbio0Tagged Adenocarcinoma of lung (disorder), Antigens, Biosciences, Cancer Therapeutic Procedure, Cartography, Cervical Atlas, Drug Development, Gilead Sciences, Neoplasms, summit, targets, Technology Platform, Triple Negative Breast Neoplasms

Gilead Sciences, Cartography Biosciences, cancer therapy, antigen targets, triple-negative breast cancer, lung adenocarcinoma, ATLAS platform, SUMMIT platform, oncology, drug development.

Revolutionizing CAR-Ts: The Future of Automation and Decentralization in Cell and Gene Therapy Manufacturing

1 year ago1 year ago talkbio0Tagged Advanced therapies, Automation, CAR-Ts, Cells, Decentralization, Digital X-ray, gene therapy, Manufacture, Patient-Centered Care, Precision Medicine, Preventive monitoring, quality management systems, real-time, Regulatory Compliance, Supply chain logistics

Automation, Decentralization, CAR-Ts, Cell and gene therapy manufacturing, Advanced therapies, Personalized medicine, Regulatory compliance, Quality management systems, Supply chain logistics, Digital solutions, Real-time monitoring, Patient-centered care